# Long-term Atogepant in Real-world Practice

> **NCT07699549** · — · COMPLETED · sponsor: **Fundación de Investigación Biomédica - Hospital Universitario de La Princesa** · enrollment: 513 (actual)

## Conditions studied

- Migraine
- Headache
- Headache (Migraine)
- Migraine Disease
- Migraine Disorder
- Migraine Headache
- Migraine Disability

## Interventions

- **DRUG:** Atogepant 60 mg
- **OTHER:** Headache diary
- **OTHER:** Patient-reported outcome measures

## Key facts

- **NCT ID:** NCT07699549
- **Lead sponsor:** Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 513 (ACTUAL)
- **Last updated:** 2026-09-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699549, "Long-term Atogepant in Real-world Practice". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07699549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*